Strengthening Transatlantic Cooperations
The first edition of the Transatlantic Conference on Personalized Medicine (TCPM) was held in 2013 on the occasion of the centennial of Erasmus University Rotterdam, ‘100 Years of Impact’, 7-8 November 2013.
Among the keynote speakers were:
Leroy Hood, Institute for Systems Biology
A world-renowned scientist, inventor, entrepreneur and visionary. His discoveries have permanently changed the course of biology, and revolutionized the understanding of genetics, life, and human health.
Peter van der Spek, Erasmus MC
The Bioinformatics Group at Erasmus MC University Medical Center Rotterdam focuses on the support of datamining and analysis. This expertise is used for fundamental research, molecular diagnostics, molecular imaging, (forensic) molecular biology and support of clinical trials.
René Medema, Netherlands Cancer Institute
His research group made key contributions to the general understanding of transcriptional control of the cell cycle and has become a significant player in the field of spindle assembly and chromosome segregation.
Atul Butte, Stanford University
Builds and applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data measured by researchers and clinicians over the past decade into diagnostics, therapeutics, and new insights into disease.
Alexander Eggermont ,Gustave Roussy Cancer Insitute
President of the Gustave Roussy Cancer Institute in Paris, France. His scientific achievements include a TNF based isolated limb perfusion program in Europe, contribution to drug development and clinical trial methodology and establishment of a world class laboratory in tumor pathopsysiology.
Emile Voest ,University Medical Center Utrecht
Head of Medical Oncology at UMCU and Chair of the Center for Personalized Cancer Treatment (CPCT), a joint effort of UMC Utrecht, Erasmus MC and The Netherlands Cancer Institute to find the best drug for the individual patient based on tumor DNA analysis.
Brian J. Druker, Oregon Health & Science University – Knight Cancer Institute
Holds the JELD-WEN Chair of Leukemia Research. In 2009 he won the Lasker Clinical Award and the Meyenburg Cancer Research Prize for his influential work in the development of STI571, commonly known as Gleevec, for the treatment of Chronic Myeloid Leukemia (CML). On November 8 2013 he was awarded a Honorary Doctorate of Erasmus University Rotterdam.
Personalized medicine is one of the important drivers for healthcare and wellbeing in the 21st century. In order to address this paradigm shift, new strategic partnerships between all stakeholders are needed. This calls for immediate agenda setting between healthcare professionals, scientists, policy makers, industry, funders and patients as healthcare consumers.
Both Europe and the USA have prioritized development and deployment of personalized medicine and care. The Netherlands, with eight university medical centers, is at the forefront of academic development in personalized medicine research as well as in personalized care. Personalized medicine will be high on the European research agenda of Horizon2020.
At the dawn of Horizon2020, the presentations and discussions have strengthened the motivation to collaborate between science, policy and industry in order to bring applications of personalized medicine within reach for the benefit of all.
TCPM2013 was an initiative of Erasmus MC and executed in close collaboration with University Medical Center Utrecht (Utrecht Life Sciences), Netherlands Cancer Institute, the Dutch Government and the Healthcare Innovation Transfer Foundation (HIT).
Listen to the Conference video interviews
- Atal Butte, Stanford University
- Brian Druker; Oregon Health and Science University
- Alexander Eggermont, Gustave Roussy Cancer Institute
- Leroy Hood, Institute for Systems Biology
- Alain Huriez, EPEMED
- Daniel Weaver, PerkinElmer, transrelational medicine
- Erick Scott, Scripps Transrelational Science Institute
- Emile Voest, University Medical Center Utrecht
- Cees Smit, European Genetic Alliances Network
- Robert Klein, BGI/Complete Genomics
- Robert Thijssen, Netherlands Office for Science and Technology
Study the conference papers
- Paper Leroy Hood, Institute for Systems Biology: Lee_Hood_paper
- Personalized Medicine: Informatics Challenges on the Road to the Clinic. Oracle White Paper: oracle_paper